Cargando…
White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
White Matter Hyperintensities (WMHs) are associated with cognitive decline in aging and Alzheimer's disease. However, the pathogenesis of cognitive decline in Parkinson's disease (PD) is not as clearly related to vascular causes, and therefore the role of WMHs as a marker of small-vessel d...
Autores principales: | Dadar, Mahsa, Zeighami, Yashar, Yau, Yvonne, Fereshtehnejad, Seyed-Mohammad, Maranzano, Josefina, Postuma, Ronald B., Dagher, Alain, Collins, D. Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176552/ https://www.ncbi.nlm.nih.gov/pubmed/30292088 http://dx.doi.org/10.1016/j.nicl.2018.09.025 |
Ejemplares similares
-
Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2019) -
Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
por: Abbasi, Nooshin, et al.
Publicado: (2019) -
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
por: Dadar, Mahsa, et al.
Publicado: (2022) -
White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s disease
por: Misquitta, Karen, et al.
Publicado: (2020) -
Network structure of brain atrophy in de novo Parkinson's disease
por: Zeighami, Yashar, et al.
Publicado: (2015)